FDA grants approval for Tendyne, first-of-its-kind device to replace the mitral valve without open-heart surgery – Abbott
Abbott announced the FDA has approved the company’s Tendyne transcatheter mitral valve replacement (TMVR) system to treat people with mitral valve disease. This life-changing therapy is available for… read more.
